New research may help explain recurrent Crohn’s disease in children

FHS
June 28, 2024
6:26 pm

Remarkable new research by a University of Virginia undergraduate may help explain recurrent Crohn’s disease in children and open the door to new ways to treat or even cure the devastating condition.

AstraZeneca posts 16% drop in Q3 2023 profit after tax

AstraZeneca’s earnings per share (EPS) on a reported basis dropped by 16% to $0.89 from $1.06 in Q3 2022. Credit: Ascannio / Shutterstock.com. AstraZeneca has

November 10, 2023

Aging: Separating the Science from the Snake Oil

Broadcast Date: May 17, 2023Time: 9:00 am PT, 12:00 pm ET, 18:00 CET In the field of aging research, the line between science and pseudoscience is blurry.

May 1, 2023

Verily lands $38 million deal with CDC for wastewater surveillance

Alphabet’s life sciences company Verily has scored its first Centers for Disease Control contract, a high profile job leaders hope will boost its brand in

October 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.